TNFAIP2 and head and neck squamous cell carcinoma: NAC reversed signaling enhancement induced by TNFAIP2 knockdown (Fig. 2l), indicating that TNFAIP2 protected HNSCC cells from cisplatin-induced apoptosis by inhibiting the ROS/JNK pathway.